BioCrude Technologies USA, Inc. Quarterly Debt-to-equity in % from Q1 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
BioCrude Technologies USA, Inc. quarterly Debt-to-equity history and growth rate from Q1 2018 to Q3 2024.
  • BioCrude Technologies USA, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -117 %, a 4.46% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -117 -4.99 -4.46% Sep 30, 2024
Q2 2024 -114 -2.2 -1.96% Jun 30, 2024
Q1 2024 -111 +1.73 +1.54% Mar 31, 2024
Q4 2023 -110 Dec 31, 2023
Q3 2023 -112 Sep 30, 2023
Q2 2023 -112 Jun 30, 2023
Q1 2023 -113 Mar 31, 2023
Q4 2021 -193 -73.6 -61.3% Dec 31, 2021
Q3 2021 -232 -124 -115% Sep 30, 2021
Q2 2021 -198 -90.3 -83.7% Jun 30, 2021
Q1 2021 -149 -40.7 -37.6% Mar 31, 2021
Q4 2020 -120 -10.5 -9.63% Dec 31, 2020
Q3 2020 -108 +4.18 +3.72% Sep 30, 2020
Q2 2020 -108 +14.7 +12% Jun 30, 2020
Q1 2020 -108 +41.5 +27.7% Mar 31, 2020
Q4 2019 -109 +103 +48.5% Dec 31, 2019
Q3 2019 -112 +70.9 +38.7% Sep 30, 2019
Q2 2019 -123 +27.8 +18.5% Jun 30, 2019
Q1 2019 -150 -24.8 -19.8% Mar 31, 2019
Q4 2018 -213 Dec 31, 2018
Q3 2018 -183 Sep 30, 2018
Q2 2018 -150 Jun 30, 2018
Q1 2018 -125 Mar 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.